Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Gac. méd. Méx ; 156(6): 615-617, nov.-dic. 2020.
Article in Spanish | LILACS | ID: biblio-1249976

ABSTRACT

Resumen Extender una receta o indicar un tratamiento suele ser la última parte de la consulta médica. Este proceso crucial puede desvirtuarse debido a múltiples factores como capacidad prescriptiva limitada, exceso de trabajo y falta de reflexión o tiempo. La información insuficiente acerca del paciente o del tratamiento afecta el proceso prescriptivo y propicia errores que pueden ser graves para la salud del enfermo. La Academia Nacional de Medicina, en consonancia con la Organización Mundial de la Salud, hace énfasis en hacer del proceso prescriptivo un ejercicio de reflexión.


Abstract Writing a prescription or indicating a treatment is usually the last part of medical consultation. This crucial process can be undermined by multiple factors such as limited prescriptive ability, overwork, and lack of reflection or time. Insufficient information about the patient or the treatment affects the prescriptive process and leads to errors that can be serious for patient health. The National Academy of Medicine, in line with the World Health Organization, emphasizes the relevance of making the prescriptive process a reflective exercise.


Subject(s)
Humans , Drug Prescriptions , Reflex , Practice Patterns, Physicians' , Conditioning, Psychological
2.
Gac. méd. Méx ; 156(6): 612-614, nov.-dic. 2020. tab
Article in Spanish | LILACS | ID: biblio-1249975

ABSTRACT

Resumen La automedicación y la autoprescripción son acciones de los pacientes; la primera como elemento del autocuidado que involucra medicamentos de venta libre y la segunda como una violación a la ley de salud, pues comprende medicamentos que solo pueden expenderse con receta. Todos los inconvenientes que se han atribuido a la automedicación en realidad lo son de la autoprescripción.


Abstract Self-medication and self-prescription are actions undertaken by patients; the former, as an element of self-care that involves over-the-counter drugs, and the latter, as a violation of the Statute of Health, since it includes drugs that can only be dispensed with a medical prescription. All the drawbacks that have been attributed to self-medication are actually associated with self-prescription.


Subject(s)
Humans , Self Care/methods , Self Medication , Self Administration , Prescription Drugs/administration & dosage , Attitude of Health Personnel
3.
Gac. méd. Méx ; 156(6): 610-611, nov.-dic. 2020.
Article in Spanish | LILACS | ID: biblio-1249974

ABSTRACT

Resumen La implementación en instituciones de salud de un cuadro básico permite adquirir y administrar una larga lista de medicamentos que presenta a los médicos las alternativas de tratamiento, así como la descripción académica colegiada de indicaciones, dosis, efectos secundarios, interacciones y análisis de costo-beneficio, con lo que se facilita la prescripción médica y la administración de insumos para la salud. El Comité de Ética y Transparencia en la Relación Médico-Industria emite diversas recomendaciones para la optimización de los beneficios generados por los cuadros básico de medicamentos.


Abstract The implementation of an essential medicines list in health institutions allows acquiring and administering a long list of drugs that offers treatment alternatives to physicians, as well as a collegiate academic description of indications, doses, side effects, interactions and cost-benefit analyses, thus facilitating medical prescription and administration of health products. The Committee of Ethics and Transparency in the Physician-Industry Relationship issues several recommendations for optimizing the benefits generated by essential medicines lists.


Subject(s)
Humans , Drug Prescriptions , Ethics Committees , Guidelines as Topic , Drugs, Essential/therapeutic use , Physicians/ethics , Cost-Benefit Analysis , Drug Industry/ethics
4.
Gac. méd. Méx ; 156(5): 467-468, sep.-oct. 2020.
Article in Spanish | LILACS | ID: biblio-1249947

ABSTRACT

Resumen Un capítulo novedoso es la atención y promoción por parte de médicos especialistas de aspectos relacionados con procedimientos estéticos, más que con la salud. La aspiración humana de la búsqueda de la belleza personal ha generado nuevos escenarios en la labor médica. El Comité de Ética y Transparencia en la Relación Médico Industria (CETREMI) de la Academia Nacional de México ha revisado esta circunstancia y emite recomendaciones tanto a los médicos como a los productores y potenciales consumidores de procedimientos estéticos.


Abstract A novel chapter in current medical settings is the promotion and attention of esthetic aspects rather than health issues by health professionals. The human aspiration related to the search for personal beauty has generated new scenarios in medical practice. The Committee on Ethics and Transparency in the Physician-Industry Relationship (CETREMI) of the National Academy of Medicine of Mexico has analyzed this phenomenon and has issued recommendations directed both to medical professionals and to producers and potential consumers of esthetic procedures.


Subject(s)
Humans , Surgery, Plastic/ethics , Beauty Culture/ethics , Guidelines as Topic , Commerce/ethics , Cosmetics , Dermatologists/ethics , Advisory Committees , Marketing/ethics , Mexico
5.
Gac. méd. Méx ; 155(5): 519-520, Sep.-Oct. 2019.
Article in English | LILACS | ID: biblio-1286554

ABSTRACT

Conflicts of interest are situations in which judgment and integrity of medical decisions or actions are influenced by a secondary interest, often of an economic nature. The Committee of Ethics and Transparency in the Physician-Industry Relationship of the National Academy of Medicine of Mexico recognizes that these conflicts occur in health professionals' daily life, but also in public and private institutions that provide health services, as well as in the academy and in research activities. Therefore, it is necessary to identify conflicting situations and always act in accordance with the patient's interest.


Subject(s)
Ethics Committees , Guidelines as Topic , Ethics, Medical , Conflict of Interest , Mexico
6.
Gac. méd. Méx ; 155(3): 319-321, may.-jun. 2019.
Article in English, Spanish | LILACS | ID: biblio-1286508

ABSTRACT

Resumen La investigación clínica es la herramienta de mayor importancia para la identificación de estrategias diagnósticas y terapéuticas que deriven en mayor eficacia y seguridad. A pesar de su trascendencia, la implementación exitosa de la investigación clínica presenta numerosas dificultades; entre las más relevantes se encuentra la poca disponibilidad de recursos para realizar ensayos clínicos independientes. Por lo general, la industria farmacéutica absorbe los costos asociados con la mayoría de los ensayos clínicos, sin embargo, esto puede generar una disociación entre los temas de interés y las prioridades en salud, al existir interés económico como principal motivación de estos protocolos. Además del papel relevante de la industria farmacéutica, es importante que las instancias gubernamentales favorezcan las condiciones, tanto económicas como regulatorias, para la implementación de investigación clínica independiente, que aborde temas de interés médico y terapéutico, aunque no genere beneficios económicos empresariales.


Abstract Clinical research is the most important tool for the identification of diagnostic and therapeutic strategies that derive in higher efficacy and safety. Despite its significance, successful implementation of clinical research faces numerous difficulties, with one the most relevant being limited availability of resources for the performance of independent clinical trials. Generally, the pharmaceutical industry absorbs the costs associated with most clinical trials; however, this can generate dissociation between subjects of interest and health priorities when economic interest is the main driver of these protocols. In addition to the relevant role played by the pharmaceutical industry, it is important that government agencies favor adequate conditions, both in economic and regulatory aspects, for the implementation of independent clinical research that addresses subjects of medical and therapeutic interest, even if it does not generate corporate economic benefits.


Subject(s)
Humans , Clinical Trials as Topic/organization & administration , Biomedical Research/organization & administration , Drug Industry/organization & administration , Financial Support , Clinical Trials as Topic/economics , Biomedical Research/economics , Drug Industry/economics
8.
Gac. méd. Méx ; 155(2): 202-203, mar.-abr. 2019.
Article in Spanish | LILACS | ID: biblio-1286485

ABSTRACT

Resumen Los médicos requieren flexibilidad para sus prescripciones. Sin embargo, algunos límites están marcados tanto por el conocimiento vigente como por las restricciones de acceso, normas y reglamentos. El Comité de Ética y Transparencia en la Relación Médico-Industria (CETREMI) propone varias sugerencias para ayudar a los pacientes, que incluyen la selección de las mejores alternativas para cada caso, la protocolización de variaciones a los estándares de prescripción (dosis, indicaciones, etcétera) por escrito en el expediente y eludir modas, novedades no probadas, argumentos simplemente publicitarios o promocionales y conflictos de interés.


Abstract Doctors require flexibility for prescription. However, some limits are laid down both by current knowledge and by restrictions imposed by access and rules and regulations. The Committee for Ethics and Transparency in the Physician-Industry Relationship (CETREMI) of the National Academy of Medicine proposes several suggestions to help patients, which include the selection of the best alternatives for each case, formalization of prescription standards variations (doses, drug indications, etc.) written down in the medical records, and avoidance of fashions, untested novelties, argumentations solely based on advertising or commercial promotion and conflicts of interest.


Subject(s)
Humans , Physicians/organization & administration , Practice Patterns, Physicians'/standards , Ethics, Medical , Physicians/ethics , Practice Patterns, Physicians'/ethics , Advisory Committees , Mexico
9.
An. otorrinolaringol. mex ; 43(1): 29-32, dic.-feb. 1998. ilus
Article in Spanish | LILACS | ID: lil-232817

ABSTRACT

La fibromatosis colli es una patología rara caracterizada por fibrosis del músculo esternocleidomastoideo, que se presenta clínicamente como una casa en el cuello. Aparece por lo general en el recién nacido, y debe reconocerse de manera temprana para proporcionar un tratamiento adecuado y oportuno. Se presenta el caso de un niño con fibromatosis colli bilateral, y se discuten aspectos de fisiopatogenia, diagnóstico y tratamiento de esta entidad


Subject(s)
Humans , Male , Infant, Newborn , Neck Muscles/abnormalities , Torticollis/congenital , Torticollis/diagnosis , Torticollis/etiology , Torticollis/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL